~~<i id='E9BA966AC7'><strike id='E9BA966AC7'><tt id='E9BA966AC7'><pre id='E9BA966AC7'></pre></tt></strike></i>~~

Home» comprehensive» knowledge

knowledge

author：comprehensive 2025-09-28 12:10:06 Page View：86439

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： GSK to buy asthma
Next article： The cancer drug shortage isn’t new — and neither are the solutions

explore

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Rep. Raul Ruiz on the physician shortage and more

BeforehejoinedCongress,Rep.RaulRuiz,aDemocratfromCalifornia,workedinanotherchaoticenvironment:theeme

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

AdobeAslateofliverdiseasesgotarebrandthisyear.Expertshopethechangecangeneratemoreconversation—andres